Richtlijn diagnostiek en behandeling van patiënten met chronische nierschade
Dit sequentiële model kan worden toegepast ten behoeve van de classificatie en behandeling van patiënten met chronische nierschade. 
Details Decision tree Files & References
Sequential
Model author
Version
1.7
Revision date
2019-02-05
MeSH terms
  • Kidney Function Test
  • Renal Insufficiency
  • Kidney Failure
  • Creatinine
  • Glomerular Filtration Rate
  • Status
    public
    Share
      • Verricht laboratoriumonderzoek
        Aanvullende diagnostiek wordt aanbevolen i.v.m. beperkte gevoeligheid van albumine teststroken.
          • Geen chronische nierfunctiestoornis
            eGFR ≥60 ml/min/1.73m2 & albuminurie classificatie A1.
          • Milde nierfunctiestoornis
            eGFR 45-59 ml/min/1.73m2 & albuminurie classificatie A1.
          • Matige nierfunctiestoonis
            eGFR 30-44 ml/min/1.73m2 & albuminurie classificatie A1.
          • Ernstige nierfunctiestoornis
            eGFR <30 ml/min/1.73m2 & albuminurie classificatie A1.
          • Milde nierfunctiestoornis
            eGFR ≥60 ml/min/1.73m2 & albuminurie classificatie A2.
          • Milde nierfunctiestoornis
            eGFR 45-59 ml/min/1.73m2 & albuminurie classificatie A2.
          • Ernstige nierfunctiestoornis
            eGFR 30-44 ml/min/1.73m2 & albuminurie classificatie A2.
          • Ernstige nierfunctiestoornis
            eGFR <30 ml/min/1.73m2 & albuminurie classificatie A2.
          • Matige nierfunctiestoornis
            eGFR ≥45 ml/min/1.73m2 & albuminurie classificatie A3.
          • Ernstige nierfunctiestoornis
            eGFR <45 ml/min/1.73m2 & albuminurie classificatie A3.
          • Geen chronische nierfunctiestoornis
            GFR ≥60 ml/min/1.73m2 & albuminurie classificatie A1.
          • Milde nierfunctiestoornis
            GFR 45-59 ml/min/1.73m2 & albuminurie classificatie A1.
          • Matige nierfunctiestoornis
            GFR 30-44 ml/min/1.73m2 & albuminurie classificatie A1.
          • Ernstige nierfuntiestoornis
            GFR <30 ml/min/1.73m2 & albuminurie classificatie A1.
          • Geen chronische nierfunctiestoornis
            GFR ≥60 ml/min/1.73m2 & albuminurie classificatie A2.
          • Milde nierfunctiestoornis
            GFR 44-59 ml/min/1.73m2 & albuminurie classificatie A2.
          • Ernstige nierfunctiestoornis
            GFR <45 ml/min/1.73m2 & albuminurie classificatie A2.
          • Matige gestoorde nierfunctie
            GFR ≥60 ml/min/1.73m2 & albuminurie classificatie A3.
          • Matig gestoorde nierfunctie
            GFR 45-59 ml/min/1.73m2 & albuminurie classificatie A3.
          • Ernstige nierfunctiestoornis
            GFR 30-44 ml/min/1.73m2 & albuminurie classificatie A3.
          • Ernstige nierfunctiestoornis
            GFR <30 ml/min/1.73m2 & albuminurie classificatie A3.

    Related files

    No related files available

    Supporting Publications

    No supporting publications available

    Sequential model

    A sequential model encompasses a number of prediction models that are linked in a decision tree of protocol, to guide you in your clinical decision making process.

    As a clinician you remain fully in control. You can follow the recommended patient specific guide lines or deviate according to your own judgement.

    Sequential models on Evidencio will minimize your registration burden. Following a sequential model will yield a patient specific report, in which you'll only have to document your deviations.

    Please register or login to use sequentials models.

    Sign In

    Sign Up

    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Which steps will you find in this sequential model?

      • Verricht laboratoriumonderzoek
        Aanvullende diagnostiek wordt aanbevolen i.v.m. beperkte gevoeligheid van albumine teststroken.
          • Geen chronische nierfunctiestoornis
            eGFR ≥60 ml/min/1.73m2 & albuminurie classificatie A1.
          • Milde nierfunctiestoornis
            eGFR 45-59 ml/min/1.73m2 & albuminurie classificatie A1.
          • Matige nierfunctiestoonis
            eGFR 30-44 ml/min/1.73m2 & albuminurie classificatie A1.
          • Ernstige nierfunctiestoornis
            eGFR <30 ml/min/1.73m2 & albuminurie classificatie A1.
          • Milde nierfunctiestoornis
            eGFR ≥60 ml/min/1.73m2 & albuminurie classificatie A2.
          • Milde nierfunctiestoornis
            eGFR 45-59 ml/min/1.73m2 & albuminurie classificatie A2.
          • Ernstige nierfunctiestoornis
            eGFR 30-44 ml/min/1.73m2 & albuminurie classificatie A2.
          • Ernstige nierfunctiestoornis
            eGFR <30 ml/min/1.73m2 & albuminurie classificatie A2.
          • Matige nierfunctiestoornis
            eGFR ≥45 ml/min/1.73m2 & albuminurie classificatie A3.
          • Ernstige nierfunctiestoornis
            eGFR <45 ml/min/1.73m2 & albuminurie classificatie A3.
          • Geen chronische nierfunctiestoornis
            GFR ≥60 ml/min/1.73m2 & albuminurie classificatie A1.
          • Milde nierfunctiestoornis
            GFR 45-59 ml/min/1.73m2 & albuminurie classificatie A1.
          • Matige nierfunctiestoornis
            GFR 30-44 ml/min/1.73m2 & albuminurie classificatie A1.
          • Ernstige nierfuntiestoornis
            GFR <30 ml/min/1.73m2 & albuminurie classificatie A1.
          • Geen chronische nierfunctiestoornis
            GFR ≥60 ml/min/1.73m2 & albuminurie classificatie A2.
          • Milde nierfunctiestoornis
            GFR 44-59 ml/min/1.73m2 & albuminurie classificatie A2.
          • Ernstige nierfunctiestoornis
            GFR <45 ml/min/1.73m2 & albuminurie classificatie A2.
          • Matige gestoorde nierfunctie
            GFR ≥60 ml/min/1.73m2 & albuminurie classificatie A3.
          • Matig gestoorde nierfunctie
            GFR 45-59 ml/min/1.73m2 & albuminurie classificatie A3.
          • Ernstige nierfunctiestoornis
            GFR 30-44 ml/min/1.73m2 & albuminurie classificatie A3.
          • Ernstige nierfunctiestoornis
            GFR <30 ml/min/1.73m2 & albuminurie classificatie A3.
    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    {{ comment.content }}
    Underlying models
    Geschatte glomerulaire filtratie snelheid: eGFR (CDK-EPI formule)
    Research authors: Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
    CKD-EPI creatinine equation (2009)
    Research authors: Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, and Coresh J.
    Estimated creatinine excretion per day (CKD epidemiology collaboration)
    Research authors: Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zang YL, Greene T, Levey AS.
    logo

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    https://www.evidencio.com/registration

    Printed results - Examples {{ new Date().toLocaleString() }}


    Evidencio Community Account Benefits


    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.